ABSTRACT
Background Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and dementia. This study aimed to examine if an increased genetic risk for CAD is associated with long-term risk of developing all-cause, Alzheimer’s, or vascular dementia, and investigate whether the presence of healthy lifestyle behaviours in the mid-to-late life period may attenuate this risk.
Methods A prospective cohort study of 365,782 participants free from dementia for at least 5 years post-baseline assessment was conducted within the UK Biobank study. Genetic risk was assessed using a genome-wide polygenic risk score (PRS) for CAD, and lifestyle risk using a modified version of the American Heart Association’s Life’s Essential 8 Lifestyle Risk Score (LRS). Primary outcomes were incident all-cause, Alzheimer’s, and vascular dementia diagnoses obtained from linked electronic health records. Secondary outcomes were neuroimaging phenotypes with well-established links to future dementia risk measured in 32,592 participants recalled for MRI imaging.
Results 8,870 cases of all-cause dementia were observed over a median 13.9-year follow-up. Higher genetic risk for CAD was associated with an elevated risk of all dementia subtypes (HRs = 1.08-1.16; p<0.001 for all). A higher LRS was associated with a modestly increased risk of all-cause dementia (HR = 1.06 [1.04-1.08]; p < 0.001), with this risk likely arising through increased rates of vascular dementia (HR = 1.22 [1.17-1.28]) as no evidence was found for any associations with Alzheimer’s disease (HR = 0.99 [0.95-1.02]; p = 0.535). Individuals with a combination of high genetic and high lifestyle risk scores for CAD were more than twice as likely to develop vascular dementia during long-term follow-up compared to those with low levels of both. This risk was substantially attenuated in those following healthy lifestyle behaviours at baseline, however, regardless of underlying genetic risk (e.g. HR for low vs high lifestyle risk scores = 1.43 [1.12-1.81] vs. 2.16 [1.73-2.69] respectively in individuals with high genetic risk). In a subset of individuals recalled for neuroimaging assessments, those with high genetic and lifestyle risk for CAD demonstrated a 30% greater volume of white matter hyperintensities than those with low risk, while showing little difference in grey matter or hippocampal volumes.
Conclusions Individuals who are genetically predisposed to developing CAD also face an increased risk of developing dementia in old age. This risk is reduced in those adopting healthy lifestyle behaviours earlier in the lifespan, however, particularly in those at risk from dementia caused by underlying vascular pathology.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Population study using a publically available biobank rather than clinical trial
Funding Statement
VG is supported by a Diabetes Research and Wellness Foundation Professor David Matthews Non-Clinical Fellowship (SCA/01/NCF/22). STC is supported by an Alzheimer?s Research UK David Carr Fellowship (ARUK-RF2021B-006).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research has been conducted using the UK Biobank Resource under Application Number 71702 and includes data provided by patients and collected by the NHS as part of their care and support. The UK Biobank study received ethical approval from the National Health Service North West Multicentre Research Ethics Committee. All participants gave informed consent during the baseline assessment. Any participants withdrawing consent prior to the commencement of this study were excluded before analysis.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data used in this publication are open access and available to bona fide researchers through well-documented processes detailed at https://www.ukbiobank.ac.uk/. The statistical code for all analyses in this paper can be found in an open-access GitHub repository located at https://github.com/scottchiesa/UKB_PRS_LRS_Dementia.
ABBREVIATIONS
- BMI
- Body mass index
- BP
- Blood pressure
- CAD
- Coronary artery disease
- CI
- Confidence interval
- CVD
- Cardiovascular disease
- HbA1c
- Haemoglobin A1c
- HR
- Hazard ratio
- ICD
- International Classification of Diseases
- LDL-C
- Low-density lipoprotein cholesterol
- LE8
- Life’s Essential 8
- LRS
- Lifestyle risk score
- PRS
- Polygenic risk score
- SD
- Standard deviation